Devices for mechanical thrombectomy for stroke and materials for hysterosalpingo sonography were added to the list of reimbursed implants and invasive devices in Belgium in July

21

Aug 2017

New material codes for neurovascular self-expanding stent retrievers for clot removal (mechanical thrombectomy for stroke) and foam preparation for hysterosalpingosonography were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in July.

Stent retrievers for restoring blood flow and retrieving clots from occluded blood vessels in the brain

  • Devices will be reimbursed using a generic tariff with no registration on the nominative list (it does not exist for stent retrievers)
  • The following procedure codes have been implemented:
    • 182136 – 182140 “One or more thrombus retrievers for endovascular intracranial mechanical thrombectomy procedure in case of ischemic stroke” with tariff of €4,500;
    • 182136 – 182140 “All the equipment for the endovascular extraction of a thrombus by aspiration or necessary for the use of a thrombus retriever during an endovascular intracranial mechanical thrombectomy procedure in case of ischemic stroke” with tariff of €3,000;
    • 182173 – 182184 “All dilatation equipment and possible stent used during endovascular treatment of proximal arterial constriction in order to have access for endovascular extraction of an intracranial thrombus in case of ischemic stroke” with tariff of €900.
  • There are specific conditions of reimbursement, provided in paragraph G-§10 of the List of reimbursable implants and invasive medical devices

Materials for foam preparation, used for hysterosalpingo foam sonography

  • Devices will be reimbursed using a generic tariff, but registration on the nominative list is required
  • The following procedure codes have been implemented:
    • 182114 - 182125 “All consumable equipment, with or without catheter, including components required for foam preparation, used for hysterosalpingo foam sonography” with tariff of €60.44;
  • Nominative list 36501 with brand-specific description of devices was created;
  • Only one product (ExEm Foam-Kit, Goodlife Pharma) has been registered in the nominative list 36501 so far;
  • There are specific conditions of reimbursement, provided in paragraph H-§05 of the List of reimbursable implants and invasive medical devices.

See full reimbursement information in Dutch or French here.

Subscribe to our newsletter delivered every second week not to miss relevant reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more